Democratic senator takes Tom Price to task over questionable stock purchases


Rep. Tom Price (R-Ga.) faced intense questioning from Sen. Patty Murray (D-Wash.) on Wednesday over his decision to purchase Innate Immunotherapeutics stock after a conversation with Rep. Chris Collins (R-N.Y.). "Rep. Price, recent press reports about your investments in the Australian biotech company, Innate Immunotherapeutics, raise some curious questions about your judgments, and I want to review the facts," Murray began. "You made the decision to purchase that stock, not a broker, yes or no?"
"That was a decision I made, yes," Price answered.
Murray continued to push in her questioning: "Congressman Chris Collins, who sits on President-elect Trump's transition team, is both an investor and a board member of [Innate Immunotherapeutics]. He was reportedly overheard just last week off the House floor bragging about how he had made people millionaires from a stock tip," she said. "Congressman Price, in our meeting, you informed me you made purchases based on conversations with Rep. Collins, is that correct?"
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Price has denied the accusation, claiming he had spoken to Collins simply about the company in general — but it's certainly not a great moment for the congressman. "[Innate Immunotherapeutics'] drug could benefit from the 21st Century Cures Act, which Mr. Price voted for. The law, signed in December, will speed up the Food and Drug Administration's approval of new medicines," The New York Times reports. "At the very least, Mr. Price exercised abysmal judgment by trading the shares of companies over whose fortunes he exercised so much control."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
Weer at Soho Theatre Walthamstow: a 'silly, seductive, slapstick joy'
The Week Recommends Natalie Palamides' 'tear-inducingly funny' one-woman show opens London's newest venue
-
Can the world stop Israel from starving Gaza?
Today's Big Question Total blockade on food and aid enters its third month, and Israel is accused of 'weaponising starvation'
-
The timely revival of watchmaking
Under The Radar Artisan horology is enjoying a surprising resurgence
-
Warren Buffet announces surprise retirement
speed read At the annual meeting of Berkshire Hathaway, the billionaire investor named Vice Chairman Greg Abel his replacement
-
Trump calls Amazon's Bezos over tariff display
Speed Read The president was not happy with reports that Amazon would list the added cost from tariffs alongside product prices
-
Markets notch worst quarter in years as new tariffs loom
Speed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
-
Tesla Cybertrucks recalled over dislodging panels
Speed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off
-
Crafting emporium Joann is going out of business
Speed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
-
Trump's China tariffs start after Canada, Mexico pauses
Speed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine